A61K 31/65
Tetracyclines
A61K31/65 (Tetracyclines) appears on 1,020 US grants and 1,840 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,020
- Published applications
- 1,840
- Assignees
- 816
- Inventors
- 2,835
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 7 | 0 |
| 1978 | 5 | 0 |
| 1979 | 2 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 3 | 0 |
| 1988 | 3 | 0 |
| 1989 | 4 | 0 |
| 1990 | 7 | 0 |
| 1991 | 6 | 0 |
| 1992 | 3 | 0 |
| 1993 | 10 | 0 |
| 1994 | 5 | 0 |
| 1995 | 6 | 0 |
| 1996 | 6 | 0 |
| 1997 | 13 | 0 |
| 1998 | 16 | 0 |
| 1999 | 8 | 0 |
| 2000 | 13 | 0 |
| 2001 | 12 | 5 |
| 2002 | 12 | 23 |
| 2003 | 21 | 57 |
| 2004 | 14 | 56 |
| 2005 | 15 | 50 |
| 2006 | 21 | 46 |
| 2007 | 11 | 56 |
| 2008 | 7 | 61 |
| 2009 | 14 | 43 |
| 2010 | 23 | 54 |
| 2011 | 26 | 52 |
| 2012 | 27 | 71 |
| 2013 | 39 | 59 |
| 2014 | 46 | 90 |
| 2015 | 49 | 92 |
| 2016 | 51 | 103 |
| 2017 | 57 | 104 |
| 2018 | 59 | 83 |
| 2019 | 58 | 113 |
| 2020 | 65 | 100 |
| 2021 | 52 | 120 |
| 2022 | 39 | 108 |
| 2023 | 44 | 91 |
| 2024 | 46 | 75 |
| 2025 | 55 | 82 |
| 2026 | 28 | 46 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for treating age-related macular degeneration29 Sep 2026US 12,746,246 B2Tufts Medical Center, Inc.
- Tetracycline derivatives for treating neurodegenerative or neuroinflammatory diseases29 Sep 2026US 12,746,247 B2Institut Du Cerveau Et De La Moelle Epiniere
- Tissue engineered vascular grafts29 Sep 2026US 12,746,309 B2Medtronic, Inc.
- Polymer and composition from renewable source29 Sep 2026US 12,747,319 B2Åbo Akademi University
- Pharmaceutical formulation22 Sep 2026US 12,740,923 B2
- Tp0751 chimera-containing vaccine1 Oct 2026US 2026/0297141 A1University of Washington
- Quantitative monitoring of drug release by enzyme-responsive polymeric nanoparticle17 Sep 2026US 2026/0273094 A1Board of Trustees of Michigan State University
- Products of manufacture and therapeutic compositions for treating, ameliorating or preventing viral infections and methods for making and using them10 Sep 2026US 2026/0263473 A1Topelia Australia Ltd.
- Combination for the treatment of infections caused by mycoplasma genitalium3 Sep 2026US 2026/0256814 A1GlaxoSmithKline Intellectual Property Development Limited
- Chemogenetics-based therapy for neurological disorders20 Aug 2026US 2026/0241036 A1Gateway Biotechnology, Inc.
Most cited
By later US patents
- Method for manufacturing a porous ceramic scaffold having an organic/inorganic hybrid coating layer containing a bioactive factor777US 8,734,831 B2Snu R&Db Foundation · 2014
- Supplemented and unsupplemented tissue sealants, methods of their production and use441US 6,197,325 B1American National Red Cross · 2001
- Antibacterial coated medical implants361US 5,217,493 ABoard of Regents, The University of Texas System · 1993
- Pharmaceutical and cosmetic carrier or composition for topical application284US 6,911,211 B2Foamix Ltd. · 2005
- Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth243US 6,861,053 B1Cedars-Sinai Medical Center · 2005